{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:46:30Z","timestamp":1792273590621,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Traditional Chinese Medicine Science and Technology Plan","award":["2026ZL0255"],"award-info":[{"award-number":["2026ZL0255"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10735-026-10986-x","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:00:54Z","timestamp":1790391654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The deubiquitinating enzyme USP42 promotes lung adenocarcinoma progression through PTGS2"],"prefix":"10.1007","volume":"57","author":[{"given":"Hainan","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5978-0966","authenticated-orcid":false,"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"issue":"4","key":"10986_CR2","doi-asserted-by":"publisher","first-page":"bqab025","DOI":"10.1210\/endocr\/bqab025","volume":"162","author":"P Anamthathmakula","year":"2021","unstructured":"Anamthathmakula P, Winuthayanon W (2021) Prostaglandin-endoperoxide synthase 2 (PTGS2) in the oviduct: roles in fertilization and early embryo development. Endocrinology 162(4):bqab025","journal-title":"Endocrinology"},{"issue":"6","key":"10986_CR1","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/cancers12061579","volume":"12","author":"AM Antao","year":"2020","unstructured":"Antao AM, Tyagi A, Kim KS et al (2020) Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics. Cancers (Basel) 12(6):1579","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10986_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12964-023-01268-0","volume":"21","author":"X Bai","year":"2023","unstructured":"Bai X, Shao J, Duan T et al (2023) Exo-miR-1290-induced by COX-2 overexpression promotes cancer-associated fibroblasts activation and tumor progression by CUL3-Nrf2 pathway in lung adenocarcinoma. Cell Commun Signa 21(1):242","journal-title":"Cell Commun Signa"},{"issue":"11","key":"10986_CR6","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.jtho.2025.06.012","volume":"20","author":"A Banerjee","year":"2025","unstructured":"Banerjee A, Vathiotis I, Halder D et al (2025) Molecular landscape and therapeutic strategies of lung cancer lineage plasticity. J Thorac Oncol 20(11):1582\u20131593","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10986_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.molmed.2024.08.004","volume":"31","author":"R Behrouzi","year":"2025","unstructured":"Behrouzi R, Clipson A, Simpson KL et al (2025) Cell-free and extrachromosomal DNA profiling of small cell lung cancer. Trends Mol Med 31(1):64\u201378","journal-title":"Trends Mol Med"},{"issue":"14","key":"10986_CR4","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1158\/0008-5472.CAN-23-2627","volume":"84","author":"J Boumelha","year":"2024","unstructured":"Boumelha J, de Castro A, Bah N et al (2024) CRISPR-Cas9 screening identifies KRAS-induced COX2 as a driver of immunotherapy resistance in lung cancer. Cancer Res 84(14):2231\u20132246","journal-title":"Cancer Res"},{"key":"10986_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molimm.2020.06.021","volume":"126","author":"D Che","year":"2020","unstructured":"Che D, Zhang S, Jing Z et al (2020) Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2\/PGE2\/\u03b2-catenin signalling pathway. Mol Immunol 126:165\u2013166","journal-title":"Mol Immunol"},{"issue":"1","key":"10986_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-021-01448-x","volume":"20","author":"SW Chen","year":"2021","unstructured":"Chen SW, Zhu SQ, Pei X et al (2021) Cancer cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934\/SHP2 axis in NSCLC. Mol Cancer 20(1):144","journal-title":"Mol Cancer"},{"key":"10986_CR8","doi-asserted-by":"publisher","first-page":"834859","DOI":"10.3389\/fcell.2022.834859","volume":"10","author":"C Chen","year":"2022","unstructured":"Chen C, Guan J, Gu X et al (2022) Prostaglandin E2 and receptors: insight into tumorigenesis, tumor progression, and treatment of hepatocellular carcinoma. Front Cell Dev Biol 10:834859","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10986_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41065-024-00343-x","volume":"161","author":"L Chen","year":"2024","unstructured":"Chen L, Xing J, Lv J et al (2024) Corynoxine suppresses lung adenocarcinoma proliferation and metastasis via inhibiting PI3K\/AKT pathway and suppressing Cyclooxygenase-2 expression. Hereditas 161(1):41","journal-title":"Hereditas"},{"issue":"2","key":"10986_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S et al (2021) Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ 28(2):591\u2013605","journal-title":"Cell Death Differ"},{"issue":"1","key":"10986_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/ijms16010307","volume":"16","author":"F Ding","year":"2014","unstructured":"Ding F, Bao C, Tian Y et al (2014) USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition. Int J Mol Sci 16(1):307\u2013320","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10986_CR13","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1111\/cas.15543","volume":"113","author":"P Fang","year":"2022","unstructured":"Fang P, Han Y, Qu Y et al (2022) EIF3B stabilizes PTGS2 expression by counteracting MDM2-mediated ubiquitination to promote the development and progression of malignant melanoma. Cancer Sci 113(12):4181\u20134192","journal-title":"Cancer Sci"},{"issue":"22","key":"10986_CR16","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.3390\/cancers17223627","volume":"17","author":"NT Garc\u00eda-Barrientos","year":"2025","unstructured":"Garc\u00eda-Barrientos NT, Solorzano-Ibarra F, Klimov-Kravtchenko K et al (2025) T cell exhaustion in the cervical cancer tumor microenvironment: PD-1 overexpression and co-expression with TIGIT, Tim-3, LAG-3, and NKG2A. Cancers (Basel) 17(22):3627","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10986_CR14","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.7150\/ijbs.127562","volume":"22","author":"K Gong","year":"2026","unstructured":"Gong K, Song K, Wang H et al (2026) Triptonide-mediated PTGS2 inhibition induces autophagic cell death to suppress the progression of triple-negative breast cancer and epithelial ovarian cancer. Int J Biol Sci 22(5):2215\u20132232","journal-title":"Int J Biol Sci"},{"issue":"10","key":"10986_CR15","doi-asserted-by":"publisher","first-page":"113139","DOI":"10.1016\/j.celrep.2023.113139","volume":"42","author":"H Gu","year":"2023","unstructured":"Gu H, Yu H, Qin L et al (2023) MSU crystal deposition contributes to inflammation and immune responses in gout remission. Cell Rep 42(10):113139","journal-title":"Cell Rep"},{"issue":"1","key":"10986_CR17","doi-asserted-by":"publisher","first-page":"36751","DOI":"10.1038\/s41598-025-20573-x","volume":"15","author":"C He","year":"2025","unstructured":"He C, Chen J, Tian R et al (2025) Deubiquitinating enzyme USP42 promotes breast cancer progression by inhibiting JNK\/p38-mediated apoptosis. Sci Rep 15(1):36751","journal-title":"Sci Rep"},{"issue":"3","key":"10986_CR18","doi-asserted-by":"publisher","first-page":"e0152997","DOI":"10.1371\/journal.pone.0152997","volume":"11","author":"K Hou","year":"2016","unstructured":"Hou K, Zhu Z, Wang Y et al (2016) Overexpression and biological function of ubiquitin-specific protease 42 in gastric cancer. PLoS ONE 11(3):e0152997","journal-title":"PLoS ONE"},{"issue":"9","key":"10986_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP (2023) The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol 20(9):624\u2013639","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10986_CR20","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/s41418-021-00763-6","volume":"28","author":"S Liu","year":"2021","unstructured":"Liu S, Wang T, Shi Y et al (2021) USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis. Cell Death Differ 28(8):2482\u20132498","journal-title":"Cell Death Differ"},{"issue":"11","key":"10986_CR21","doi-asserted-by":"publisher","first-page":"e010201","DOI":"10.1136\/jitc-2024-010201","volume":"12","author":"TL McMiller","year":"2024","unstructured":"McMiller TL, Besharati S, Yarchoan M et al (2024) Immune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy. J Immunother Cancer 12(11):e010201","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10986_CR22","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1038\/s41467-025-60092-x","volume":"16","author":"A Peura","year":"2025","unstructured":"Peura A, Turpin R, Liu R et al (2025) Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling. Nat Commun 16(1):4908","journal-title":"Nat Commun"},{"issue":"5","key":"10986_CR23","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1073\/pnas.1612920114","volume":"114","author":"V Prima","year":"2017","unstructured":"Prima V, Kaliberova LN, Kaliberov S et al (2017) COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proc Natl Acad Sci U S A 114(5):1117\u20131122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10986_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.lungcan.2012.02.017","volume":"77","author":"SM Rausch","year":"2012","unstructured":"Rausch SM, Gonzalez BD, Clark MM et al (2012) SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. Lung Cancer 77(1):217\u2013223","journal-title":"Lung Cancer"},{"issue":"36","key":"10986_CR24","doi-asserted-by":"publisher","first-page":"e2303807","DOI":"10.1002\/advs.202303807","volume":"10","author":"J Ren","year":"2023","unstructured":"Ren J, Yu P, Liu S et al (2023) Deubiquitylating Enzymes in Cancer and Immunity. Adv Sci (Weinh) 10(36):e2303807","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"10986_CR28","doi-asserted-by":"publisher","first-page":"188636","DOI":"10.1016\/j.bbcan.2021.188636","volume":"1876","author":"T Singh","year":"2021","unstructured":"Singh T, Fatehi Hassanabad M, Fatehi Hassanabad A (2021) Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents. Biochim Biophys Acta Rev Cancer 1876(2):188636","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"10986_CR27","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/ijms26052049","volume":"26","author":"B Smolarz","year":"2025","unstructured":"Smolarz B, \u0141ukasiewicz H, Samulak D et al (2025) Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature). Int J Mol Sci 26(5):2049","journal-title":"Int J Mol Sci"},{"key":"10986_CR29","doi-asserted-by":"publisher","first-page":"969032","DOI":"10.3389\/fonc.2022.969032","volume":"12","author":"Y Sun","year":"2023","unstructured":"Sun Y, He P, Li L et al (2023) The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer. Front Oncol 12:969032","journal-title":"Front Oncol"},{"issue":"3","key":"10986_CR26","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10986_CR30","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3390\/ijms25031522","volume":"25","author":"E Teixeira","year":"2024","unstructured":"Teixeira E, Fernandes C, Bung\u0103rdean M et al (2024) Investigating USP42 mutation as underlying cause of familial non-medullary thyroid carcinoma. Int J Mol Sci 25(3):1522","journal-title":"Int J Mol Sci"},{"issue":"32","key":"10986_CR31","doi-asserted-by":"publisher","first-page":"e2425621122","DOI":"10.1073\/pnas.2425621122","volume":"122","author":"JA Vuille","year":"2025","unstructured":"Vuille JA, Tanriover C, Antmen E et al (2025) The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis. Proc Natl Acad Sci U S A 122(32):e2425621122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10986_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fphar.2019.00427","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Kang W, You Y et al (2019) USP7: novel drug target in cancer therapy. Front Pharmacol 10:427","journal-title":"Front Pharmacol"},{"key":"10986_CR34","doi-asserted-by":"publisher","first-page":"795034","DOI":"10.3389\/fgene.2021.795034","volume":"12","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen C (2022) The downregulation of PTGS2 mediated by ncRNAs is tightly correlated with systemic sclerosis-interstitial lung disease. Front Genet 12:795034","journal-title":"Front Genet"},{"issue":"13","key":"10986_CR33","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1158\/0008-5472.CAN-07-0141","volume":"67","author":"K Xu","year":"2007","unstructured":"Xu K, Shu HK (2007) EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1\/Sp3 transcription factors in human gliomas. Cancer Res 67(13):6121\u20136129","journal-title":"Cancer Res"},{"issue":"11","key":"10986_CR36","doi-asserted-by":"publisher","first-page":"e1898","DOI":"10.1002\/onco.13921","volume":"26","author":"G Zhang","year":"2021","unstructured":"Zhang G, Xia P, Zhao S et al (2021) Gefitinib combined with cetuximab for the treatment of lung adenocarcinoma harboring the EGFR-intergenic region (SEC61G) fusion and EGFR amplification. Oncologist 26(11):e1898\u2013e1902","journal-title":"Oncologist"},{"key":"10986_CR37","doi-asserted-by":"publisher","first-page":"113198","DOI":"10.1016\/j.jinorgbio.2025.113198","volume":"277","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Zhao J, Shen Z et al (2026) Cyclometalated iridium complex as a PD-L1 inhibitor: suppressing expression via COX-2 blockade. J Inorg Biochem 277:113198","journal-title":"J Inorg Biochem"},{"key":"10986_CR35","doi-asserted-by":"publisher","first-page":"1646331","DOI":"10.3389\/fmolb.2025.1646331","volume":"12","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Chen C, Meng Y et al (2025) Targeting USP42 induces DNA damage and inhibits cell growth in prostate cancer. Front Mol Biosci 12:1646331","journal-title":"Front Mol Biosci"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10986-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10986-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10986-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:19:30Z","timestamp":1792271970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10986-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10986"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10986-x","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"318"}}